Skip to main content
TipRanks
Go Ultimate75% OFF

InMode (154) Q1 2026 Earnings Report

3 Followers

DE:154 Q1 2026 EPS Results

Actual EPS
EUR 0.23
Consensus EPS
EUR 0.27
Beat/Miss
Missed by -EUR 0.04
One Year Ago EPS
EUR 0.28

DE:154 Q1 2026 Revenue Results

Actual Revenue
EUR 74.14M
Expected Revenue
EUR 72.17M
Beat/Miss
Beat by +EUR 1.97M
YoY Revenue Growth
+5.32%

Earnings Announcement Details

Quarter
Q1 2026
Date
05/06/2026
Time
Before Open
Conference Call
Wednesday, May 6, 2026
DE:154 Upcoming Earnings

InMode's next earnings date is estimated for February 10, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

DE:154 Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

Q1 2026
Earnings Call Date:May 06, 2026|% Change Since:-2.89%|
Earnings Call Sentiment|Neutral

The call contained a mix of modest top-line progress and strategic positives (5% revenue growth, strong cash balance, product launches, sales reorganization and share repurchases) offset by notable margin compression, rising operating expenses and declines in EPS. Management provided steady full-year guidance and described early signs of stabilization in the U.S., but profitability pressures and macroeconomic headwinds temper the outlook. International and product development initiatives offer upside, while near-term margin and demand uncertainty are the primary negatives.

Company Guidance

The company reiterated 2026 guidance calling for revenue of $365–$375 million, non‑GAAP gross margin of 74%–76%, non‑GAAP income from operations of $73–$78 million, and non‑GAAP diluted EPS of $1.33–$1.38; for context, Q1 results included $82.0 million revenue, 75% non‑GAAP gross margin, 17% non‑GAAP operating margin, $0.25 non‑GAAP diluted EPS and $15.4 million cash from operations, while the balance sheet held $537.2 million in cash/marketable securities and the company returned capital via $127.4 million repurchases in 2025 plus $52.7 million year‑to‑date in 2026 (3.86 million shares).

  • Revenue GrowthTotal revenue of $82.0M in Q1 2026, up 5% from $77.9M in Q1 2025, driven primarily by stronger U.S. performance.
  • Solid International Mix and GrowthInternational sales of $38.7M represented 48% of total sales and increased ~2.65% year-over-year; company operates in 100+ countries with Europe performing strongly.
  • Strong Balance Sheet and Cash GenerationCash, cash equivalents, marketable securities and deposits totaled $537.2M as of 3/31/2026; generated $15.4M from operating activities in Q1.
  • Product Momentum — Laser Platforms ContributingNewer platforms (Pico and CO2) made meaningful contributions to Q1 revenue and expand the company’s procedure offering; Erbium laser development targeting FDA clearance by year-end to further broaden portfolio.
  • Sales Organization Changes and Early StabilizationNorth America reorganized to a unified model (new leadership installed end of Q3 2025) and Envision ophthalmology/optometry sales force now operates independently (30 reps); management reports early signs of stabilization, especially in the U.S., with particularly strong progress in March.
  • Capital Return and OptionalitySignificant share repurchases: $127.4M repurchased in 2025 and $52.7M year-to-date under the 2026 program (~3.86M shares YTD); management states all capital allocation options (buybacks, M&A, dividends) remain on the table.
  • Clear 2026 Guidance ProvidedReiterated full-year 2026 guidance: revenue $365M–$375M; non-GAAP gross margin 74%–76%; non-GAAP income from operations $73M–$78M; non-GAAP diluted EPS $1.33–$1.38.

DE:154 Earnings History

DE:154 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 10, 20272026 (Q4)0.32-0.42――
Nov 11, 20262026 (Q3)0.290.330.34-2.63% (-0.01)
Aug 05, 20262026 (Q2)0.300.310.42-26.38% (-0.11)
May 06, 20262026 (Q1)0.270.230.28-19.35% (-0.05)
Feb 10, 20262025 (Q4)0.380.420.389.52% (+0.04)
Nov 05, 20252025 (Q3)0.320.340.63-45.71% (-0.29)
Jul 30, 20252025 (Q2)0.370.420.3138.24% (+0.12)
Apr 28, 20252025 (Q1)0.320.280.29-3.13% (-0.01)
Feb 04, 20252024 (Q4)0.480.380.64-40.85% (-0.26)
Oct 30, 20242024 (Q3)0.510.630.5514.75% (+0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed